Header

UZH-Logo

Maintenance Infos

Publications for Andrade-Villanueva, J

Navigate back| Up a level
Export as
Group by:
Jump to:
Number of items: 4.

2018

Caro-Vega, Yanink; Schultze, Anna; W Efsen, Anne Marie; Post, Frank A; Panteleev, Alexander; Skrahin, Aliaksandr; Miro, Jose M; Girardi, Enrico; Podlekareva, Daria N; Lundgren, Jens D; Sierra-Madero, Juan; Toibaro, Javier; Andrade-Villanueva, Jaime; Tetradov, Simona; Fehr, Jan; Caylà, Joan; Losso, Marcelo H; Miller, Robert F; Mocroft, Amanda; Kirk, Ole; Crabtree-Ramírez, Brenda (2018). Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. BMC Infectious Diseases, 18(1):191.

2015

Gallant, Joel E; Koenig, Ellen; Andrade-Villanueva, Jaime; Chetchotisakd, Ploenchan; DeJesus, Edwin; Antunes, Francisco; Arastéh, Keikawus; Rizzardini, Giuliano; Fehr, Jan; Liu, Hui C; Abram, Michael E; Cao, Huyen; Szwarcberg, Javier (2015). Brief report: cobicistat compared with ritonavir as a pharmacoenhancer for atazanavir in combination with emtricitabine/tenofovir disoproxil fumarate: week 144 results. Journal of Acquired Immune Deficiency Syndromes, 69(3):338-340.

2013

Gallant, Joel E; Koenig, Ellen; Andrade-Villanueva, Jaime; Chetchotisakd, Ploenchan; DeJesus, Edwin; Antunes, Francisco; Arastéh, Keikawus; Moyle, Graeme; Rizzardini, Giuliano; Fehr, Jan; Liu, Yapei; Zhong, Lijie; Callebaut, Christian; Szwarcberg, Javier; Rhee, Martin S; Cheng, Andrew K (2013). Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results. Journal of Infectious Diseases, 208(1):32-39.

2011

Soriano, V; Arastéh, K; Migrone, H; Lutz, T; Opravil, M; Andrade-Villanueva, J; Antunes, F; Di Perri, G; Podzamczer, D; Taylor, S; Domingo, P; Gellermann, H; de Rossi, L (2011). Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN trial. Antiviral Therapy, 16(3):339-348.

This list was generated on Mon Jul 16 19:21:45 2018 CEST.